Search

everythinglearnresearchcommunity

for

Search:↓

Overall alcohol consumption decreased during lockdown, but heavy drinkers consumed more.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

During the COVID-19 pandemic, dermatology visits decreased, especially among older patients, patients of color, men, and those with chronic conditions.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

The pandemic changed how often certain skin conditions were diagnosed.

Severe COVID-19 often leads to hair loss in India.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Possible link between androgens and COVID-19 severity; more research needed.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

GLP-1RA therapy may increase the risk of hair loss.

Isotretinoin can cause hair loss, and reducing the dose or using supplements like vitamin D and iron may help.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

Many skin issues in hospitalized adults go unnoticed, needing better checks and teamwork.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Long-COVID symptoms in children after MIS-C are similar across different COVID-19 variants, with older age being a key factor.